Modulation of Neuronal Nicotinic Receptor by Quinolizidine Alkaloids Causes Neuroprotection on a Cellular Alzheimer Model

Journal of Alzheimer's Disease

Volumn 42, Issue 1, 2014, Pages 143-155

  Araya, Juan A ^a   Ramírez, Alejandra E ^a   Figueroa Aroca, Daniela ^a   Sotes, Gastón J ^a   Pérez, Claudia ^a   Becerra, Jose ^a   Saez Orellana, Francisco ^a   Guzmán, Leonardo ^a   Aguayo, Luis G ^a   Fuentealba, Jorge ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Alkaloids; Alzheimer's disease; neuroprotection; nicotinic receptor; Teline monspessulana

Indexed keywords

ALKALOID; AMYLOID BETA PROTEIN; ATROPINE; BOTULINUM TOXIN A; NEUROPROTECTIVE AGENT; NICOTINIC RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN BCL 2; PROTEIN KINASE B; QUINOLIZIDINE DERIVATIVE; TELINE MONSPESSULANA EXTRACT; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN[1-40]; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CALCIUM CELL LEVEL; CELL SURVIVAL; CELL VIABILITY; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; HEK293 CELL LINE; HIPPOCAMPAL NEURONAL CULTURE; HUMAN; HUMAN CELL; MEDICINAL PLANT; NERVE CELL NETWORK; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PC12 CELL LINE; PLANT SEED; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; TELINE MONSPESSULANNA; ANIMAL; BRAIN CORTEX; CELL CULTURE; DRUG EFFECTS; FABACEAE; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYTOTHERAPY; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ALKALOIDS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; FABACEAE; HEK293 CELLS; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT EXTRACTS; QUINOLIZIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SEEDS; SYNAPTIC TRANSMISSION;

EID: 84916595109     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132045     Document Type: Article

References (49)

1. Price BH, Gurvit H, Weintraub S, Geula C, Leimkuhler E, Mesulam M (1993) Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease. Arch Neurol 50, 931-937.
2. Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283, 29639-29643.
3. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2005) A specific amyloid- protein assembly in the brain impairs memory. Nature 440, 352-357.
4. Fuentealba J, Dibarrart AJ, Fuentes-Fuentes MC, Saez- Orellana F, Quiñones K, Guzmán L, Perez C, Becerra J, Aguayo LG (2011) Synaptic failure and adenosine triphosphate imbalance induced by amyloid - aggregates are prevented by blueberry-enriched polyphenols extract. J Neurosci Res 89, 1499-1508.
5. Aguayo LG, Parodi J, Sepúlveda FJ, Opazo C (2009) Pore-forming neurotoxin-like mechanism for Aβ oligomerinduced synaptic failure. In Current Hypotheses and Research Milestones in Alzheimer's Disease, Maccioni RB, Perry G, eds. Springer Press, pp. 13-21.
6. Camandola S, Mattson MP (2010) Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim Biophys Acta 1813, 965-973.
7. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31, 454-463.
8. Bartus RT(2000)Onneurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163, 495-529.
9. Craig LA, Hong NS, McDonald RJ (2011) Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci Biobehav Rev 35, 1397-1409.
10. Suh Y- H, Checler F (2002) Amyloid precursor protein, presenilins, and α-synuclein: Molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev 54, 469-525.
11. Kawamata J, Shimohama S (2011) Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 24, 95-109.
12. Pappas BA, Bayley PJ, Bui BK, Hansen LA, Thal LJ (2000) Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Neurobiol Aging 21, 11-17.
13. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH(1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 2, 1457-1459.
14. Mousavi M, Hellström-Lindahl E, Guan ZZ, Shan KR, Ravid R, Nordberg A (2003) Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease. Neuroscience 122, 515-520.
15. Jonnala RR, Terry AV, Jr., Buccafusco JJ (2002) Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. Life Sci 70, 1543-1554.
16. Li X, Arias E, Jonnala R, Mruthinti S, Buccafusco J (2005) Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo. J Mol Neurosci 27, 325-336.
17. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, Maeda T, Akaike A (1998) Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity. Brain Res 792, 331-334.
18. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A (2001) α7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block Aβ-amyloid-induced neurotoxicity. J Biol Chem 276, 13541-13546.
19. Yu W, Mechawar N, Krantic S, Quirion R (2011) α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. J Neurochem 119, 848-858.
20. Akaike A, Takada-Takatori Y, Kume T, Izumi Y (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of α4 and α7 receptors in neuroprotection. J Mol Neurosci 40, 211-216.
21. Daly JW (2005) Nicotinic agonists, antagonists, and modulators from natural sources. Cell Mol Neurobiol 25, 513-552.
22. Cordell GA, Quinn-Beattie ML, Farnsworth NR (2001) The potential of alkaloids in drug discovery. Phytother Res 15, 183-205.
23. Barlow RB, McLeod LJ (1969) Some studies on cytisine and its methylated derivatives. Br J Pharmacol 35, 161-174.
24. Fitch RW, Kaneko Y, Klaperski P, Daly JW, Seitz G, Gündisch D (2005) Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors. Bioorg Med Chem Lett 15, 1221-1224.
25. Cassels BK, Bermúdez I, Dajas F, Abin-Carriquiry JA, Wonnacott S (2005) From ligand design to therapeutic efficacy: The challenge for nicotinic receptor research. Drug Discov Today 10, 1657-1665.
26. del Barrio L, Martín-de-Saavedra MD, Romero A, Parada E, Egea J, Avila J, McIntosh JM, Wonnacott S, López MG (2011) Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented byα7 andβ2 nicotinic stimulation. Toxicol Sci 123, 193-205.
27. Parodi J, Sepulveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG(2010) Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285, 2506-2514.
28. Sepulveda FJ, Parodi J, Peoples RW, Opazo C, Aguayo LG (2010) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 5, e11820.
29. Ferreiro E, Eufrasio A, Pereira C, Oliveira CR, Rego AC (2007) Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimers Dis 12, 223-228.
30. Latini A, da Silva CG, Ferreira GC, Schuck PF, Scussiato K, Sarkis JJ, Dutra Filho CS, Wyse AT, Wannmacher CM, Wajner M (2005) Mitochondrial energy metabolism is markedly impaired by D-2-hydroxyglutaric acid in rat tissues. Mol Genet Metab 86, 188-199.
31. Xia YP, Dai RL, Li YN, Mao L, Xue YM, He QW, Huang M, Huang Y, Mei YW, Hu B (2012) The protective effect of sonic hedgehog is mediated by the propidium iodide 3- kinase/AKT/BCL-2 pathway in cultured rat astrocytes under oxidative stress. Neuroscience 209, 1-11.
32. Fuentealba J, Dibarrart A, Saez-Orellana F, Fuentes-Fuentes MC, Oyanedel CN, Guzmán J, Perez C, Becerra J, Aguayo LG (2012) Synaptic silencing and plasma membrane dyshomeostasis induced by amyloid-β peptide are prevented by Aristotelia chilensis enriched extract. J Alzheimers Dis 31, 879-889.
33. Alabi AA, Tsien RW (2013) Perspectives on kiss-and-run: Role in exocytosis, endocytosis, and neurotransmission. Ann Rev Physiol 75, 393-422.
34. Parodi J, Sepúlveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG(2010) Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285, 2506-2514.
35. Sepulveda FJ, Parodi J, Peoples RW, Opazo C, Aguayo LG (2010) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 5, e11820.
36. Chauhan NB, Siegel GJ (2002) Reversal of amyloid β toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid β antibody. J Neurosci Res 69, 10-23.
37. Fuentealba J, Olivares R, Ales E, Tapia L, Rojo J, Arroyo G, Aldea M, Criado M, Gandia L, Garcia AG (2004) A choline-evoked [Ca2+]c signal causes catecholamine release and hyperpolarization of chromaffin cells. FASEB J 18, 1468-1470.
38. Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, Bertrand D (1996) Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. J Neurosci 16, 7880-7891.
39. Chu M, Guo J, Chen C-Y (2005) Long-term exposure to nicotine, via Ras pathway, induces cyclin D1 to stimulate G1 cell cycle transition. J Biol Chem 280, 6369-6379.
40. Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E, Chellappan S (2006) Nicotine induces cell proliferation by β-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest 116, 2208-2217.
41. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111, 81-90.
42. Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16, 869-871.
43. Zwart R, Vijverberg HPM (1997) Potentiation and Inhibition of neuronal nicotinic receptors by atropine: Competitive and noncompetitive effects. Mol Pharmacol 52, 886-895.
44. González-Rubio JM, García de Diego AM, Egea J, Olivares R, Rojo J, Gandía L, García AG, Hernández-Guijo JM (2006) Blockade of nicotinic receptors of bovine adrenal chromaffin cells by nanomolar concentrations of atropine. Eur J Pharmacol 535, 13-24.
45. Abbott JJ, Howlett DR, Francis PT, Williams RJ (2008) Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. Neurobiol Aging 29, 992-1001.
46. Magrane J, Rosen KM, Smith RC, Walsh K, Gouras GK, Querfurth HW(2005) Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci 25, 10960-10969.
47. Akaike A, Takada-Takatori Y, Kume T, Izumi Y (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci 40, 211-216.
48. Kawamata J, Shimohama S (2011) Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 24(Suppl 2), 95-109.
49. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A (2001) alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276, 13541-13546.